Advertisement
Research Article| Volume 19, ISSUE 1, P187-238, March 1999

Download started.

Ok

Diagnosis of Childhood Acute Myeloid Leukemia

  • Fred G. Behm
    Correspondence
    Address reprint requests to: Fred G. Behm, MD, Department of Pathology and Laboratory Medicine, St. Jude Children’s Research Hospital, 332 North Lauderdale St., Memphis, TN 38105.
    Affiliations
    From the Department of Pathology and Laboratory Medicine, St. Jude Children’s Research Hospital, Memphis, Tennessee
    Search for articles by this author
DOI:https://doi.org/10.1016/S0272-2712(18)30135-5
Diagnosis of Childhood Acute Myeloid Leukemia
Previous ArticleAcute Lymphoblastic Leukemia
Next ArticleIntrauterine Fetal Diagnosis for Hematologic and Other Congenital Disorders
      This paper is only available as a PDF. To read, Please Download here.
      Since 1985, our knowledge of the biology of acute leukemias has been greatly enhanced by new investigative tools and techniques. This new information in turn has produced improved diagnostic criteria, new classifications, and tailored therapeutic approaches for the acute leukemias. The intent of the following article is to present the clinical and laboratory features that facilitate a diagnosis of AML and provide insight into the biologic basis and treatment of these disorders.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Ademokun A.J.
        • Irving J.A.E.
        • Maung Z.T.
        • et al.
        Basophilia, t(15;17) translocation and atypical AML.
        Leukemia. 1995; 9: 225
        • Adriaansen H.J.
        • te Boekhorst P.A.W.
        • Hagemeijer A.M.
        • et al.
        Acute myeloid leukemia M4 with bone marrow eosinophilia (M4Eo) and inv(16)(p13q22) exhibits a specific immunophenotype with CD2 expression.
        Blood. 1993; 81: 3043
        • Adriaansen H.J.
        • van Dongen J.J.M.
        • Hooijkaas H.
        • et al.
        Translocation (6;9) may be associated with a specific TdT-positive immunological phenotype in ANLL.
        Leukemia. 1988; 2: 136
        • Al-Omar H.M.
        • Khalil S.
        • Sher G.D.
        • et al.
        Leukemias—cytogenetics, molecular markers in diagnosis and prognosis.
        Blood. 1997; 90: 207
        • Arthur D.C.
        • Bloomfield C.D.
        Partial deletion of the long arm of chromosome 16 and bone marrow eosinophilia in acute nonlymphocytic leukemia: A new association.
        Blood. 1983; 61: 994
        • Ashfaq R.
        • Weinberg A.G.
        • Argyle C.A.
        Acute megakaryoblastic leukemia simulating carcinoma.
        Am J Clin Pathol. 1992; 98: 55
        • Ashman L.K.
        • Roberts M.M.
        • Gadd S.J.
        • et al.
        Expression of a 150-kD cell surface antigen identified by monoclonal antibody YB5.B8 is associated with poor prognosis in acute non-lymphoblastic leukaemia.
        Leuk Res. 1988; 12: 923
        • Austin G.E.
        • Chan W.C.
        • Zhao W.
        • et al.
        Myeloperoxidase gene expression in normal granulopoiesis and acute leukemias.
        Leukemia Lymphoma. 1994; 15: 209
        • Aventin A.
        • Mateu R.
        • Martino R.
        • et al.
        A case of cryptic acute promyelocytic leukemia.
        Leukemia. 1998; 12: 1490
        • Bain B.J.
        Classification of acute leukaemia: The need to incorporate cytogenetic and molecular genetic information.
        J Clin Pathol. 1998; 51: 420
        • Baranger L.
        • Baruchel A.
        • Leverger G.
        • et al.
        Monosomy-7 in childhood hemopoietic disorders.
        Leukemia. 1990; 4: 345
        • Behm F.G.
        • Raimondi S.C.
        • Schell M.J.
        • et al.
        Lack of CD45 antigen on blast cells in childhood acute lymphoblastic leukemia is associated with chromosome hyperdiploidy and other favorable prognostic features.
        Blood. 1992; 79: 1011
        • Behm F.G.
        • Shurtleff S.A.
        • Raimondi S.C.
        • et al.
        A retrospective study of the frequency of AML1/ETO, CBFß/MY11, PML/RARα, and rearrangements of MLL in childhood de novo AML and comparison with survival.
        Blood. 1997; 90: 63
        • Bello-Fernandez C.
        • Matyash M.
        • Strobl H.
        • et al.
        Analysis of myeloid-associated genes in human hematopoietic progenitor cells.
        Exp Hematol. 1997; 25: 1158
        • Bellucci S.
        • Han Z.C.
        • Pidard D.
        • et al.
        Identification of a normal human bone marrow cell population co-expressing megakaryocytic and erythroid markers in culture.
        Eur J Haematol. 1992; 48: 259
        • Ben-Bassat I.
        • Gale R.P.
        Hybrid acute leukemia.
        Leuk Res. 1986; 8: 929
        • Ben-Ezra J.
        • Sheibani K.
        • Hwang D.L.
        • et al.
        Megakaryocyte synthesis is the source of epidermal growth factor in human platelets.
        Am J Pathol. 1990; 137: 755
        • Ben-Ezra J.
        • Weinberg C.D.
        • Wu A.
        • et al.
        Leu-9 (CD7) positivity in acute leukemias: A marker of T-cell lineage?.
        Hematol Pathol. 1987; 1: 147
        • Bennett J.M.
        • Catovsky D.
        • Daniel M.T.
        • et al.
        Criteria for the diagnosis of acute leukemia of megakaryocytic lineage (M7). A report of the French-American-British Cooperative Group.
        Ann Intern Med. 1985; 103: 460
        • Bennett J.M.
        • Catovsky D.
        • Daniel M.T.
        • et al.
        Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group.
        Ann Intern Med. 1985; 103: 620
        • Bennett J.M.
        • Catovsky D.
        • Daniel M.T.
        • et al.
        Proposal for the recognition of minimally differentiated acute myeloid leukemia (AML-MO).
        Br J Haematol. 1991; 78: 325
        • Bernard P.
        • Dachary D.
        • Reiffers J.
        • et al.
        Acute nonlymphocytic leukemia with marrow eosinophilia and chromosome 16 abnormality: A report of 18 cases.
        Leukemia. 1989; 3: 740
        • Bernier M.
        • Massy M.
        • Deleeuw N.
        • et al.
        Immunological definition of acute minimally differentiated myeloid leukemia (MO) and acute undifferentiated leukemia (AUL).
        Leuk Lymph. 1995; 18: 13
        • Betz S.A.
        • Foucar K.
        • Head D.R.
        • et al.
        False-positive flow cytometric platelet glycoprotein Ilb/IIIa expression in myeloid leukemias secondary to platelet adherence to blasts.
        Blood. 1992; 79: 2399
        • Bhatia S.
        • Neglia J.P.
        Epidemiology of childhood acute myelogenous leukemia.
        J Pediatr Hematol Oncol. 1995; 17: 94
        • Bitter M.A.
        • Le Beau M.M.
        Comparison of eosinophils in acute nonlymphocytic leukaemia associated with the t(8;21) and inv(16).
        Br J Haematol. 1985; 59: 185
        • Bitter M.A.
        • Le Beau M.M.
        • Larson R.A.
        • et al.
        A morphologic and cytochemical study of acute myelomonocytic leukemia with abnormal marrow eosinophils associated with inv(16)(p13q22).
        Am J Clin Pathol. 1984; 81: 733
        • Bitter M.A.
        • Le Beau M.M.
        • Rowley J.D.
        • et al.
        Associations between morphology, karyotype and clinical features in myeloid leukemias.
        Hum Pathol. 1987; 18: 211
        • Borowitz M.J.
        • Guenther K.L.
        • Shults K.E.
        • et al.
        Immunophenotyping of acute leukemia by flow cytometric analysis. Use of CD45 and right-angle light scatter to gate on leukemia blasts in three-color analysis.
        Am J Clin Pathol. 1993; 100: 534
        • Borowitz M.J.
        • Shuster J.J.
        • Civin Cl
        • et al.
        Prognostic significance of CD34 expression in childhood B-precursor acute lymphocytic leukemia: A Pediatric Oncology Group study.
        J Clin Oncol. 1990; 8: 1389
        • Borowitz M.J.
        • Shuster J.J.
        • Land V.J.
        • et al.
        Myeloid antigen expression in childhood acute lymphoblastic leukemia.
        N Engl J Med. 1991; 325: 1379
        • Borrow J.
        • Goddard A.D.
        • Sheer D.
        • et al.
        Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17.
        Science. 1990; 249: 1577
        • Borrow J.
        • Shipley J.
        • Howe K.
        • et al.
        Molecular analysis of simple variant translocations in acute promyelocytic leukemia.
        Genes Chromosomes Cancer. 1994; 9: 234
        • Borrow J.
        • Stanton Jr, V.P.
        • Andresen J.M.
        • et al.
        the translocation t(8;16)(p11;p13) of acute myeloid leukemia fuses a putative acetyltransferase to the CREB-binding protein.
        Nat Genet. 1996; 14: 33
        • Bos J.L.
        Ras oncogenes in human cancer: A review.
        Cancer Res. 1989; 49: 4682
        • Breton-Gorius J.
        • Lewis J.C.
        • Guichard J.
        • et al.
        Monoclonal antibodies specific for human platelet membrane glycoproteins bind to monocytes by focal absorption of platelet membrane fragments: An ultrastructural immunogold study.
        Leukemia. 1987; 1: 131
        • Breton-Gorius J.
        • Reyes F.
        • Duhamel G.
        • et al.
        Megakaryoblastic acute leukemia: Identification by the ultra-structural demonstration of platelet peroxidase.
        Blood. 1978; 51: 45
        • Breton-Gorius J.
        • Villeval J.L.
        • Kieffer N.
        • et al.
        Limits of phenotypic markers for the diagnosis of megakaryoblastic leukemia.
        Blood Cells. 1989; 15: 259
        • Breton-Gorius J.
        • Villeval J.L.
        • Mitjavila M.T.
        • et al.
        Ultrastructural and cytochemical characterization of blasts from early erythroblastic leukemias.
        Leukemia. 1987; 1: 173
        • Brizard A.
        • Guilhot F.
        • Huret J.L.
        • et al.
        The 8p11 anomaly in “monoblastic” leukaemia.
        Leuk Res. 1988; 12: 693
        • Buccheri V.
        • Shetty V.
        • Yoshida N.
        • et al.
        The role of an anti-myeloperoxidase antibody in the diagnosis and classification of acute leukaemia: A comparison with light and electron microscopy cytochemistry.
        Br J Haematol. 1992; 80: 62
        • Buckley J.D.
        • Robison L.L.
        • Swotinsky R.
        • et al.
        Occupational exposures of parents of children with acute nonnonlymphocytic leukemia: A report from the Children’s Cancer Study Group.
        Cancer Res. 1989; 49: 4030
        • Campana D.
        • Hansen-Hagge T.E.
        • Matutes E.
        • et al.
        Phenotypic, genotypic, cytochemical, and ultrastructural characterization of acute undifferentiated leukemia.
        Leukemia. 1990; 4: 620
        • Campbell L.J.
        • Challis J.
        • Fok T.
        • et al.
        Chromosome 16 abnormalities associated with myeloid malignancies.
        Genes Chrom Cancer. 1991; 3: 55
        • Carroll A.
        • Civin C.
        • Schneider N.
        • et al.
        The t(1;22)(p13;q23) is nonrandom and is restricted to infants with acute megakaryoblastic leukemia: A Pediatric Oncology Group study.
        Blood. 1991; 78: 748
        • Carter M.
        • Kalwinsky D.K.
        • Dahl G.V.
        • et al.
        Childhood acute promyelocytic leukemia: A rare variant of nonlymphoid leukemia with distinctive clinical and biological features.
        Leukemia. 1989; 3: 298
        • Castilla L.H.
        • Wijemga C.
        • Wang Q.
        • et al.
        Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFß-MYH11.
        Cell. 1996; 87: 687
        • Chan G.C.F.
        • Wang W.C.
        • Raimondi S.C.
        • et al.
        Myelodysplastic syndrome in children: Differentiation from acute myeloid leukemia with a low blast count.
        Leukemia. 1997; 11: 206
        • Chan W.C.
        • Brynes R.K.
        • Kim T.H.
        • et al.
        Acute megakaryoblastic leukemia in early childhood.
        Blood. 1983; 62: 92
        • Chen S.J.
        • Zelent A.
        • Tong J.H.
        • et al.
        Rearrangements of the retinoic acid receptor alpha and promyelocytic leukemia zinc finger genes resulting from t(11;17)(q23;q21) in a patient with acute promyelocytic leukemia.
        J Clin Invest. 1993; 91: 2260
        • Cheson B.D.
        • Cassileth P.A.
        • Head D.R.
        • et al.
        Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia.
        J Clin Oncol. 1990; 8: 813
        • Chessels J.M.
        • Sieff C.A.
        • Harvey B.A.M.
        • et al.
        Monosomy 7 in childhood: A preleukemic state.
        Br J Haematol. 1981; 49: 129
        • Claxton D.F.
        • Reading C.L.
        • Nagarajan L.
        • et al.
        Correlation of CD2 expression with PML gene breakpoints in patients with acute promyelocytic leukemia.
        Blood. 1992; 80: 582
        • Cline M.J.
        The molecular basis of leukemia.
        N Engl J Med. 1994; 330: 328
        • Corey S.J.
        • Locker J.
        • Oliveri D.R.
        • et al.
        A nonclassical translocation involving 17q12 (retinoic acid receptor a) in acute promyelocytic leukemia (APML) with atypical features.
        Leukemia. 1994; 8: 1350
        • Creutzig U.
        • Ritter J.
        • Vormoor J.
        • et al.
        Myelodysplasia and acute myelogenous leukemia in Down’s syndrome. A report of 40 children of the AML-BFM Study Group.
        Leukemia. 1996; 10: 1677
        • Cuneo A.
        • Ferrant A.
        • Michaux J.L.
        • et al.
        Cytogenetic profile of minimally differentiated (FAB MO) acute myeloid leukemia: Correlation with clinicobiologic findings.
        Blood. 1995; 85: 3688
        • Cuneo A.
        • Mecucci C.
        • Kerim S.
        • et al.
        Multipotent stem cell involvement in megakaryoblastic leukemia: Cytologic and cytogenetic evidence in 15 patients.
        Blood. 1989; 74: 1781
        • Daghistani D.
        • Toledano S.R.
        • Curless R.
        Monosomy 7 syndrome. Clinical heterogeneity in children and adolescents.
        Cancer Genet Cytogenet. 1990; 44: 263
        • Das Gupta A.
        • Advani S.H.
        • Nair C.N.
        • et al.
        Acute leukemia and coexpression of lymphoid and myeloid phenotypes.
        Hematol Oncol. 1987; 5: 189
        • Debili N.
        • Coulombel L.
        • Croisille L.
        • et al.
        Characterization of a bipotent erythro-megakaryocytic progenitor in human bone marrow.
        Blood. 1996; 88: 1284
        • Debili N.
        • Kieffer N.
        • Mitjavila M.T.
        • et al.
        Expression of platelet glycoproteins by erythroid blasts in four cases of trisomy 21.
        Leukemia. 1989; 3: 669
        • Del Poeta G.
        • Stasi R.
        • Venditti A.
        • et al.
        Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
        Leukemia. 1994; 8: 388
        • Dercksen M.W.
        • Weimar I.S.
        • Rihel D.J.
        • et al.
        The value of flow cytometric analysis of platelet glycoprotein expression on CD34+ cells measured under conditions that prevent p-selectin-mediated binding of platelets.
        Blood. 1995; 86: 3771
        • De Salvo L.
        • Weir-Medina J.
        • Gomez-Sanchez O.
        • et al.
        Leucemia promielocitica aguda en el occidente de Venezuela.
        Sangre. 1989; 34: 329
        • de The H.
        • Chomienne C.
        • Lanotte M.
        • et al.
        The t(15;17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor gene to a novel transcriptional locus.
        Nature. 1990; 347: 558
        • Dharmasena F.
        • Wickham N.
        • McHugh P.J.
        • et al.
        Osteolytic tumors in acute megakaryoblastic leukemia.
        Cancer. 1986; 58: 2273
        • Dierlamm J.
        • Stul M.
        • Vranckx H.
        • et al.
        FISH identifies inv(16)(p13q22) masked by translocations in three cases of acute myeloid leukemia.
        Genes Chromosomes Cancer. 1998; 22: 87
        • Dijkstra K.
        • Kluin-Nelemans H.C.
        No difference between cytochemical and immunological detection of myeloperoxidase in AML.
        Br J Haematol. 1990; 75: 630
        • Di Noto R.
        • Lo Pardo C.
        • Schiavone E.M.
        • et al.
        Stem cell factor receptor (c-kit, CD117) is expressed on blast cells from most immature types of acute myeloid malignancies but is also a characteristic of a subset of acute promyelocytic leukaemia.
        Br J Haematol. 1996; 92: 562
        • Diverio D.
        • LoCocco F.
        • D’Adamo F.
        • et al.
        Identification of DNA rearrangements at the retinoic acid receptor-a (RAR-α) locus in all patients with acute promyelocytic leukemia (APL) and mapping of APL breakpoints within the RAR-α second intron.
        Blood. 1992; 79: 3331
        • Diverio D.
        • Pandolfi P.P.
        • Rossi V.
        • et al.
        Monitoring the treatment outcome in acute promyelocytic leukemia by RT-PCR.
        Leukemia. 1994; 8: 1105
        • Diverio D.
        • Rossi V.
        • Avvisati G.
        • et al.
        Early detection of relapse by prospective reverse transcriptase-polymerase chain reaction analysis of the PML-RARa fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP Multicenter “AIDA” trial.
        Blood. 1998; 92: 784
        • Dong F.
        • Brynes R.K.
        • Tidow N.
        • et al.
        Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia.
        N Engl J Med. 1995; 333: 487
        • Downing J.R.
        • Head D.R.
        • Curcio-Brint A.M.
        • et al.
        An AML1/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the t(8;21)(q22;q22) translocation.
        Blood. 1993; 81: 2860
        • Drexler H.G.
        • Thiel E.
        • Ludwig W.D.
        Acute myeloid leukemia expressing lymphoid-associated antigens: Diagnostic incidence and prognostic significance.
        Leukemia. 1993; 7: 489
        • Dyck J.A.
        • Maul G.G.
        • Miller W.H.
        • et al.
        A novel macromolecular structure is a target of the promyelocytic-retinoic acid receptor oncoprotein.
        Cell. 1994; 76: 333
        • Eguchi M.
        • Ozawa T.
        • Sakakibara H.
        • et al.
        Ultrastructural and ultracytochemical differences between megakaryoblastic leukemia in children and adults. Analysis of 49 patients.
        Cancer. 1992; 70: 451
        • Erber W.N.
        • Breton-Gorius J.
        • Villeval J.L.
        • et al.
        Detection of cells of megakaryocytic lineage in haematopoietic malignancies by immuno-alkaline phosphatase labelling cell smears with a panel of monoclonal antibodies.
        Br J Haematol. 1987; 65: 87
        • Erickson P.
        • Gao J.
        • Chang K.S.
        • et al.
        Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt.
        Blood. 1992; 80: 1825
        • Evans J.P.M.
        • Czepulkowski B.
        • Gibbons B.
        • et al.
        Childhood monosomy 7 revisited.
        Br J Haematol. 1988; 69: 41
        • Falini B.
        • Flenghi L.
        • Fagioli M.
        • et al.
        Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML).
        Blood. 1997; 90: 4046
        • Fenu S.
        • Carmini D.
        • Mancini F.
        • et al.
        Acute myeloid leukemias M2 potentially misdiagnosed as M3 variant French-American-Britain (FAB) subtype: A transitional form?.
        Leukemia Lymphoma. 1995; 18: 49
        • Ferrara F.
        • Di Noto R.
        • Annunziata M.
        • et al.
        Immunophenotypic analysis enables the correct prediction of t(8;21) in acute myeloid leukaemia.
        Br J Haematol. 1998; 102: 444
        • Ferrucci P.F.
        • Grignani F.
        • Pearson M.
        • et al.
        Cell death induction by the acute promyelocytic leukemia-specific PML/RARa fusion protein.
        Proc Natl Acad Sci U S A. 1997; 94: 10901
        • Fink F.M.
        • Koller U.
        • Mayer H.
        • et al.
        Prognostic significance of myeloid-associated antigen expression on blast cells in children with acute lymphoblastic leukemia.
        Med Pediatr Oncol. 1993; 21: 340
        • Foley R.
        • Soamboonsrup P.
        • Kouroukis T.
        • et al.
        PML/RARa APL with undifferentiated morphology and stem cell immunophenotype.
        Leukemia. 1998; 12: 1492
        • Fong C.T.
        • Brodeur G.M.
        Down’s syndrome and leukemia: Epidemiology, genetics, cytogenetics and mechanisms of leukemogenesis.
        Cancer Genet Cytogenet. 1987; 28: 55
        • Ford A.M.
        • Ridge S.A.
        • Cabrera M.E.
        • et al.
        In utero rearrangements in the trithorax-related oncogene in infant leukaemias.
        Nature. 1993; 363: 358
        • Foucar K.
        Bone Marrow Pathology. ASCP Press, Chicago1995
        • Fourth International Workshop on Chromosomes in Leukemia, 1982
        Rearrangements of 11q.
        Cancer Genet Cytogenet. 1984; 11: 294
        • Geller R.B.
        • Zahurak M.
        • Flurwitz C.A.
        • et al.
        Prognostic importance of immunopheno-typing in adults with acute myelocytic leukaemia: The significance of the stem-cell glycoprotein CD34 (MylO).
        Br J Haematol. 1990; 76: 340
        • Gilbert R.D.
        • Karabus C.D.
        • Mills A.E.
        Acute promyelocytic leukemia. A childhood cluster.
        Cancer. 1987; 59: 933
        • Giles R.H.
        • Dauwerse J.G.
        • Higgins C.
        • et al.
        Detection of CBP rearrangements in acute myelogenous leukemia with the t(8;16).
        Leukemia. 1997; 11: 2087
        • Giles R.H.
        • Petrij F.
        • Dauwerse J.G.
        • et al.
        The translocation t(8;16) in ANLL M4/M5 disrupts the CBP gene on chromosome 16.
        Blood. 1995; 86: 35
        • Gillio A.P.
        • Gabrilove J.L.
        Cytokine treatment of inherited bone marrow failure syndromes.
        Blood. 1993; 81: 1669
        • Gogineni S.K.
        • Shah H.O.
        • Chester M.
        • et al.
        Variant complex translocations involving chromosomes 1, 9, 9, 15 and 17 in acute promyelocytic leukemia without RARa/PML gene fusion rearrangement.
        Leukemia. 1997; 11: 514
        • Golomb H.M.
        • Rowley J.D.
        • Vardiman J.W.
        • et al.
        “Microgranular” acute promyelocytic leukemia: A distinct clinical, ultrastructural, and cytogenetic entity.
        Blood. 1980; 55: 253
        • Grimwade D.
        • Walker H.
        • Oliver F.
        • et al.
        The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered on the MRC AML 10 trial.
        Blood. 1998; 92: 2322
        • Guglielmi C.
        • Martelli M.P.
        • Diverio D.
        • et al.
        Immunophenotype of adult and childhood acute promyelocytic leukaemia: Correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases.
        Br J Haematol. 1998; 102: 1035
        • Gurney J.G.
        • Severson I.L.K.
        • Davis S.
        • et al.
        Incidence of cancer in children in the United States. Sex, race, and 1-year age specific rates by histologic type.
        Cancer. 1995; 75: 2186
        • Gyger M.
        • Bonny Y.
        • Forest L.
        Childhood monosomy 7 syndrome.
        Am J Hematol. 1982; 13: 329
        • Haferlach T.
        • Löffler H.
        • Nickenig C.
        • et al.
        Cell lineage involvement in acute promyelocytic leukaemia (APL) using a combination of May-Grunwald-Giemsa staining and fluorescence in situ hybridization for the detection of the translocation t(15;17) (q22;q12).
        Br J Haematol. 1998; 103: 93
        • Hanslip J.I.
        • Swansbury G.J.
        • Pinkerton R.
        • et al.
        The translocation t(8;16)(p11;p13) defines an AML subtype with distinct cytologic and clinical features.
        Leuk Lymphoma. 1992; 6: 479
        • Hayhoe F.G.J.
        • Quaglino D.
        Haematological Cytochemistry. Churchill Livingstone, Edinburgh1994
        • Head D.R.
        • Behm F.
        • Raimondi S.
        • et al.
        Genetic heterogeneity of acute myeloid leukemia (AML) with FAB-AML M3 morphology.
        Lab Invest. 1995; 72: 112
        • Heil G.
        • Ganser A.
        • Raghavachar A.
        • et al.
        Induction of myeloperoxidase in five cases of acute unclassified leukemia.
        Br J Haematol. 1988; 68: 23
        • Heim S.
        • Avanzi G.C.
        • Billstrom R.
        • et al.
        A new specific chromosomal rearrangement, t(8;16)(p11;p13), in acute monocytic leukemia.
        Br J Haematol. 1987; 66: 323
        • Hirt A.
        • Luethy A.R.
        • Mueller B.
        • et al.
        Acute megakaryoblastic leukemia in children identified by immunological marker studies.
        Am J Pediatr Hematol Oncol. 1990; 12: 27
        • Hoffbrand A.V.
        • Pettit J.E.
        Color Atlas of Clinical Flaematology. ed 2. Mosby-Wolfe, London1994
        • Holmes R.
        • Keating M.J.
        • Cork A.
        • et al.
        A unique pattern of central nervous system leukemia in acute myelomonocytic leukemia associated with inv(16)(p13q22).
        Blood. 1985; 65: 1071
        • Huang W.
        • Sun G.-L.
        • Li X.-S.
        • et al.
        Acute promyelocytic leukemia; clinical relevance of two major PML-RARa isoforms and detection of minimal residual disease by retrotranscriptase/polymerase chain reaction of predict relapse.
        Blood. 1993; 82: 1264
        • Hurwitz C.A.
        • Raimondi S.C.
        • Head D.
        • et al.
        Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children.
        Blood. 1992; 80: 3182
        • Hurwitz C.A.
        • Schell M.J.
        • Pui C.H.
        • et al.
        Adverse prognostic features in 251 children treated for acute myeloid leukemia.
        Med Pediatr Oncol. 1993; 21: 1
        • Immamura N.
        • Kuramoto A.
        Analysis of peroxidase negative acute leukemias by monoclonal antibodies: III. Acute lymphoblastic leukemia.
        J Clin Lab Anal. 1989; 3: 88
        • Jensen A.W.
        • Hokland M.
        • Jorgensen H.
        • et al.
        Solitary expression of CD7 among T-cell antigens in acute myeloid leukemia: identification of a group of patients with similar T-cell receptor beta and delta rearrangements and course of disease suggestive of poor prognosis.
        Blood. 1991; 78: 1292
        • Kaira R.
        • Dale D.
        • Freedman M.
        • et al.
        Monosomy 7 and activating RAS mutations accompany malignant transformation in patients with congenital neutropenia.
        Blood. 1995; 86: 4579
        • Kalwinsky D.K.
        • Raimondi S.C.
        • Schell M.J.
        • et al.
        Prognostic importance of cytogenetic subgroups in de novo pediatric acute nonlymphocytic leukemia.
        J Clin Oncol. 1990; 8: 75
        • Kita K.
        • Miwa H.
        • Nakase K.
        • et al.
        Clinical importance of CD7 expression in acute myelocytic leukemia.
        Blood. 1993; 81: 2399
        • Kita K.
        • Nakase K.
        • Miwa H.
        • et al.
        Phenotypical characteristics of acute myelocytic leukemia associated with the t(8;21)(q22;q22) chromosomal abnormality: Frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34.
        Blood. 1992; 80: 470
        • Kanakura Y.
        • Ikeda H.
        • Kitayama H.
        • et al.
        Expression, function and activation of the proto-oncogene c-kit product in human leukemia cells.
        Leuk Lymphoma. 1993; 10: 35
        • Kojima S.
        • Matsuyama T.
        • Sato T.
        • et al.
        Down’s syndrome and acute leukemia in children: An analysis of phenotype by use of monoclonal antibodies and electron microscopic platelet peroxidase reaction.
        Blood. 1990; 76: 2348
        • Krause J.R.
        • Penchansky L.
        • Contis L.
        • et al.
        Flow cytometry in the diagnosis of acute leukemia.
        Am J Clin Pathol. 1988; 89: 341
        • Krause J.R.
        • Stoic V.
        • Kaplan S.S.
        • et al.
        Microgranular promyelocytic leukemia: A multiparameter examination.
        Am J Hematol. 1989; 30: 158
        • Krissansen G.W.
        • Lucas C.M.
        • Stomski F.C.
        • et al.
        Blood leukocytes bind platelet glycoprotein (IIb-IIIa) but do not express the vitronectin receptor.
        Internati Immunol. 1990; 2: 267
        • Kuerbitz S.J.
        • Civin C.I.
        • Krischer J.P.
        • et al.
        Expression of myeloid-associated and lymphoid-associated cell-surface antigens in acute myeloid leukemia of childhood: A Pediatric Oncology Group Study.
        J Clin Oncol. 1992; 10: 1419
        • Kusec R.
        • Laczika K.
        • Knobl P.
        • et al.
        AML1/ETO fusion mRNA can be detected in remission blood samples of all patients with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation.
        Leukemia. 1994; 8: 735
        • Lacombe F.
        • Durrieu F.
        • Briais A.
        • et al.
        Flow cytometry CD45 gating for immunopheno-typing of acute myeloid leukemia.
        Leukemia. 1997; 11: 1878
        • Laczika K.
        • Mitterbauer G.
        • Korninger L.
        • et al.
        Rapid achievement of PML-RARa polymerase chain reaction (PCR)-negativity by combined treatment with all -trans retinoic acid and chemotherapy in acute promyelocytic leukemia. A pilot study.
        Leukemia. 1994; 8: 1
        • Lamond A.I.
        • Earnshaw W.C.
        Structure and function of the nucleus.
        Science. 1998; 280: 547
        • Langabeer S.E.
        • Walker H.
        • Gale R.E.
        • et al.
        Frequency of CBFß/MYH11 fusion transcripts in patients entered into the U.K. MRC AML trials.
        Br J Haematol. 1997; 96: 736
        • Larson R.A.
        • Williams S.F.
        • Le Beau M.M.
        • et al.
        Acute myelomonocytic leukemia with abnormal eosinophils and inv(16) or t(16;16) has a favorable prognosis.
        Blood. 1986; 68: 1242
        • Le Beau M.M.
        • Larson R.A.
        • Bitter M.A.
        • et al.
        Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic-clinicopathologic association.
        N Engl J Med. 1983; 309: 630
        • LeBlanc T.
        • Auvrignon A.
        • Michel G.
        • et al.
        Prognosis value of cytogenetics in 250 children with acute myeloblastic leukemia treated in the LAME 89/91 protocol.
        Blood. 1996; 88: 634
        • Lee E.J.
        • Pollack A.
        • Leavitt R.D.
        • et al.
        Minimally differentiated acute nonlymphocytic leukemia: A distinct entity.
        Blood. 1987; 70: 1400
        • Lee E.J.
        • Yang J.
        • Leavitt R.D.
        • et al.
        The significance of CD34 and TdT determination in patients with untreated de novo acute myeloid leukemia.
        Leukemia. 1992; 6: 1203
        • Lemons R.S.
        • Keller S.
        • Gietzen D.
        • et al.
        Acute promyelocytic leukemia.
        J Pediatr Hematol Oncol. 1995; 17: 198
        • Leverger G.
        • Bernheim A.
        • Daniel M.T.
        • et al.
        Cytogenetic study of 130 childhood acute nonlymphocytic leukemias.
        Med Pediatr Oncol. 1988; 16: 227
        • Licht J.D.
        • Chomienne C.
        • Goy A.
        • et al.
        Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17).
        Blood. 1995; 85: 1083
        • Lillington D.M.
        • MacCallum P.K.
        • Lister T.A.
        • et al.
        Translocation t(6;9)(p23;q34) in acute myeloid leukemia without myelodysplasia or basophilia; two cases and a review of the literature.
        Leukemia. 1993; 7: 527
        • Liu P.P.
        • Hajra A.
        • Wijmenga C.
        • et al.
        Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia.
        Blood. 1995; 85: 2289
        • Liu P.P.
        • Tarle S.A.
        • Hajra A.
        • et al.
        Fusion between transcription for CBFß/PEBP2ß and a myosin heavy chain in acute myeloid leukemia.
        Science. 1993; 261: 1041
        • Liu P.P.
        • Wijmenga C.
        • Hajra A.
        • et al.
        Identification of the chimeric protein product of the CBFB-MYH11 fusion gene in inv(16) leukemia cells.
        Genes Chromosomes Cancer. 1996; 16: 77
        • Lo Coco F.
        • Avvisati G.
        • Diverio D.
        • et al.
        Rearrangements of the RARa gene in acute promyelocytic leukaemia: Correlations with morphology and immunophenotype.
        Br J Haematol. 1991; 78: 494
        • Lo Coco F.
        • Diverio D.
        • Pandolfi P.P.
        • et al.
        Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukaemia.
        Lancet. 1992; 340: 1437
        • Look A.T.
        Oncogenic transcription factors in the human acute leukemias.
        Science. 1997; 278: 1059
        • Lu G.
        • Altman A.J.
        • Benn P.A.
        Review of the cytogenetic changes in acute megakaryo-blastic leukemia: one disease or several?.
        Cancer Genet Cytogenet. 1993; 67: 81
        • Lubbert M.
        • Mirro Jr, J.
        • Kitchingman G.
        • et al.
        Prevalence of N-Ras mutations in children with myelodysplastic syndromes and acute myeloid leukemias.
        Oncogene. 1992; 7: 263
        • Ludwig W.D.
        • Harbott J.
        • Bartram C.D.
        • et al.
        Incidence and prognostic significance of immunophenotypic subgroups in childhood acute lymphoblastic leukemia: Experience of BFM Study 86.
        in: Ludwig W.D. Thiel E. Recent Advances in Cell Biology of Acute Leukemia. Springer-Verlag, New York1993
        • Luna-Fineman S.
        • Shannon K.M.
        • Lange B.J.
        Childhood monosomy 7: Epidemiology, biology, and mechanistic implications.
        Blood. 1995; 85: 1985
        • Maarek O.
        • Jonveaux P.
        • Le-Coniat M.
        • et al.
        Fanconi anemia and bone marrow clonal chromosome abnormalities.
        Leukemia. 1996; 10: 1700
        • Malkin D.
        • Freedman M.H.
        Childhood erythroleukemia: Review of clinical and biological features.
        Am J Pediatr Hematol Oncol. 1989; 11: 348
        • Mandelli F.
        • Diverio D.
        • Avvisati G.
        • et al.
        Molecular remission in PML/RARα-positive acute promyelocytic leukemia by combined all -trans retinoic acid and idarubicin (AIDA) therapy.
        Blood. 1997; 90: 1014
        • Marcucci G.
        • Livak K.J.
        • Bi W.
        • et al.
        Detection of minimal residual disease in patients with AMLl/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay.
        Leukemia. 1998; 12: 1482
        • Martinez-Climent J.A.
        • Espinosa R.
        • Thirman M.J.
        • et al.
        Abnormalities of chromosome band 11q23 and the MLL gene in pediatric myelomonocytic and monoblastic leukemias: Identification of the t(9;ll) as an indicator of long survival.
        J Pediatr Hematol Oncol. 1995; 17: 277
        • Martinez-Climent J.A.
        • Lane N.J.
        • Rubin C.M.
        • et al.
        Clinical and prognostic significance of chromosomal abnormalities in childhood acute myeloid leukemia de novo.
        Leukemia. 1995; 9: 95
        • Maruyama F.
        • Stass S.A.
        • Estey E.H.
        • et al.
        Detection of AML1/ETO fusion transcript as a tool for diagnosing t(8;21) positive acute myelogenous leukemia.
        Leukemia. 1994; 8: 40
        • Maseki N.
        • Miyoshi H.
        • Shimizu K.
        • et al.
        The 8;21 chromosome translocation in acute myeloid leukemia is always detectable by molecular analysis using AML1.
        Blood. 1993; 81: 1573
        • Maslak P.
        • Miller Jr, W.H.
        • Heller G.
        • et al.
        CD2 expression and PML/RARa transcripts in acute promyelocytic leukemia.
        Blood. 1993; 81: 1666
        • McKenna R.W.
        • Parkin J.
        • Bloomfield C.D.
        • et al.
        Acute promyelocytic leukaemia: A study of 39 cases with identification of a hyperbasophilic microgranular variant.
        Br J Haematol. 1982; 50: 201
        • Mechtersheimer G.
        • Barth T.
        • Ludwig R.
        • et al.
        Differential expression of leukocyte differentiation antigens in small round blue cell sarcomas.
        Cancer. 1993; 71: 237
        • Mechtersheimer G.
        • Staudter M.
        • Möller P.
        Expression of the natural killer cell-associated antigens CD56 and CD57 in human neural and striated muscle cells and in their tumors.
        Cancer Res. 1991; 51: 1300
        • Miles D.K.
        • Freedman M.H.
        • Stephens K.
        • et al.
        Patients of hematopoietic lineage involvement in children with neurofibromatosis type I and malignant myeloid disorders.
        Blood. 1996; 88: 4314
        • Miller R.W.
        Deaths from childhood leukemia and solid tumors among twins and other sibs in the United States, 1960-67.
        J Natl Cancer Inst. 1971; 46: 203
        • Miller R.W.
        • Young Jr, J.L.
        • Novakovic B.
        Childhood cancer.
        Cancer. 1995; 75: 395
        • Miller Jr, W.H.
        • Kakizuka A.
        • Frankel S.R.
        • et al.
        Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor α clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia.
        Proc Natl Acad Sei U S A. 1992; 89: 2694
        • Mirro J.
        • Zipf T.F.
        • Pui C.H.
        • et al.
        Acute mixed lineage leukemia: Clinicopathologic correlations and prognostic significance.
        Blood. 1985; 66: 1115
        • Miyazono K.
        • Takaku F.
        Platelet-derived growth factors.
        Blood Rev. 1989; 3: 269
        • Morita S.
        • Tsuchiya S.
        • Fujie H.
        • et al.
        Cell surface c-kit receptors in human leukemia cell lines and pediatric leukemia: Selective preservation of c-kit expression on mega-karyoblastic cell lines during adaptation to in vitro culture.
        Leukemia. 1996; 10: 102
        • Mrozek K.
        • Heinonen H.
        • Lawrence D.
        • et al.
        Adult patients with de novo acute myeloid leukemia and t(9;11)(p22;q23) have a superior outcome to patients with other translocations involving band 11q23: A Cancer and Leukemia Group B study.
        Blood. 1997; 90: 4532
        • Myint H.
        • Lucie N.P.
        The prognostic significance of the CD34 antigen in acute myeloid leukemia.
        Leuk Lymphoma. 1992; 7: 425
        • Naparstek E.
        Granulocyte colony-stimulating factor, congenital neutropenia, and acute myeloid leukemia.
        N Engl J Med. 1995; 333: 516
        • Neame P.B.
        • Soamboonsrup P.
        • Leber B.
        • et al.
        Morphology of acute promyelocytic leukemia with cytogenetic or molecular evidence for the diagnosis: Characterization of additional microgranular variants.
        Am J Hematol. 1997; 56: 131
        • Nucifora G.
        • Larson R.A.
        • Rowley J.D.
        Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long term remission.
        Blood. 1993; 82: 712
        • Nur S.
        • Anwar M.
        • Saleem M.
        • et al.
        Disseminated intravascular coagulation in acute leukemia at first diagnosis.
        Eur J Haematol. 1995; 55: 78
        • Osato M.
        • Asou N.
        • Okubo T.
        • et al.
        Myelomonoblastic leukemia cells carrying the PEBP2β/MYH11 fusion gene are CD34 +, c-KIT + immature cells.
        Br J Haematol. 1997; 97: 656
        • Paietta E.
        Proposals for the immunological classification of acute leukemias.
        Leukemia. 1995; 9: 2147
        • Paietta E.
        • Anderson J.
        • Gallagher R.
        • et al.
        The immunophenotype of acute promyelocytic leukemia (APL): An ECOG study.
        Leukemia. 1994; 8: 1108
        • Paietta E.
        • Wiernik P.H.
        • Andersen J.
        • et al.
        Acute myeloid leukemia M4 with inv(16)(p13q22) exhibits a specific immunophenotype with CD2 expression.
        Blood. 1993; 82: 2595
        • Pandolfi P.P.
        PML, PLZF and NPM genes in the molecular pathogenesis of acute promyelocytic leukemia.
        Haematologica. 1996; 81: 472
        • Parkin D.M.
        • Stiller C.A.
        • Draper G.J.
        • et al.
        The international incidence of childhood cancer.
        Inti J Cancer. 1988; 42: 511
        • Pearson M.G.
        • Vardiman J.W.
        • Le Beau M.M.
        • et al.
        Increased numbers of marrow basophils may be associated with a t(6;9) in ANLL.
        Am J Hematol. 1985; 18: 393
        • Penchansky L.
        • Taylor S.R.
        • Krause J.R.
        Three infants with acute megakaryoblastic leukemia simulating metastatic tumor.
        Cancer. 1989; 64: 1366
        • Petrij F.
        • Giles R.H.
        • Dauwerse J.G.
        • et al.
        Rubinstein-Taybi syndrome is caused by mutations in the transcriptional co-activator CBP.
        Nature. 1995; 376: 348
        • Pilkington G.R.
        • Pallesen G.
        Phenotypic characteristics of non-hematopoietic small cell tumors of childhood with monoclonal antibodies to leukocytes, epithelial cells and cytoskeletal proteins.
        Histopathol. 1989; 14: 347
        • Praxedes M.K.
        • de Oliveira L.Z.
        • Pereira W.D.V.
        • et al.
        Monoclonal antibody anti-MPO is useful in recognizing minimally differentiated acute myeloid leukaemia.
        Leuk Lymphoma. 1994; 12: 233
        • Pui C.H.
        Acute leukemia in children.
        Curr Opin Hematol. 1996; 3: 249
        • Pui C.H.
        • Behm F.G.
        • Crist W.M.
        Clinical and biological relevance of immunologic marker studies in childhood acute lymphoblastic leukemia.
        Blood. 1993; 82: 343
        • Pui C.H.
        • Behm F.G.
        • Kalwinsky D.K.
        • et al.
        Clinical significance of low levels of myeloperoxidase positivity in childhood acute nonlymphoblastic leukemia.
        Blood. 1987; 70: 51
        • Pui C.-H.
        • Behm F.G.
        • Raimondi S.C.
        • et al.
        Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia.
        N Engl J Med. 1989; 321: 136
        • Pui C.H.
        • Behm F.G.
        • Singh B.
        • et al.
        Myeloid-associated antigen expression lacks prognostic value in childhood acute lymphoblastic leukemia treated with intensive multiagent chemotherapy.
        Blood. 1990; 75: 198
        • Pui C.H.
        • Hancock M.L.
        • Head D.R.
        • et al.
        Clinical significance of CD34 expression in childhood acute lymphoblastic leukemia.
        Blood. 1993; 82: 889
        • Pui C.H.
        • Raimondi S.C.
        • Borowitz M.J.
        • et al.
        Immunophenotypes and karyotypes of leukemic cells in children with Down’s syndrome and acute lymphoblastic leukemia.
        J Clin Oncol. 1993; 11: 1361
        • Pui C.H.
        • Raimondi S.C.
        • Head D.R.
        • et al.
        Characterization of childhood acute leukemia with multiple myeloid and lymphoid markers at diagnosis and at relapse.
        Blood. 1991; 78: 1327
        • Pui C.H.
        • Ribeiro R.C.
        • Hancock M.L.
        • et al.
        Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia.
        N Engl J Med. 1991; 325: 1682
        • Pui C.H.
        • Rivera G.
        • Mirro J.
        • et al.
        Acute megakaryoblastic leukemia: Blast cell aggregates simulating metastatic tumor.
        Arch Pathol Lab Med. 1985; 109: 1033
        • Pui C.H.
        • Schell M.J.
        • Raimondi S.C.
        • et al.
        Myeloid-antigen expression in childhood acute lymphoblastic leukemia.
        N Engl J Med. 1991; 325: 1378
        • Pui C.H.
        • Williams D.L.
        • Scarborough V.
        • et al.
        Acute megakaryoblastic leukaemia associated with intrinsic platelet dysfunction and constitutional ring 21 chromosome in a young boy.
        Br J Haematol. 1982; 50: 191
        • Quignon F.
        • DeBels F.
        • Koken M.
        • et al.
        PML induces a novel caspase-independent death process.
        Nature Genet. 1998; 20: 259
        • Rabbitts T.H.
        Chromosomal translocations in human cancer.
        Nature. 1994; 372: 143
        • Raimondi S.C.
        • Kalwinsky D.K.
        • Hayashi Y.
        • et al.
        Cytogenetics of childhood acute nonlymphocytic leukemia.
        Cancer Genet Cytogenet. 1989; 40: 13
        • Raimondi S.C.
        • Ravindranath Y.
        • Chang M.
        • et al.
        EFS does not differ significantly among 11q23 subgroups in childhood AML: Pediatric Oncology Group study 8821.
        Blood. 1998; 92: 481
        • Rainer R.O.
        • Hodges L.
        • Seltzer G.T.
        CD45 gating correlates with bone marrow differential.
        Cytometry. 1995; 22: 139
        • Ravindranath Y.
        • Steuber C.P.
        • Krischer J.
        • et al.
        High-dose cytarabine for intensification of early therapy of childhood acute myeloid leukemia: A Pediatric Oncology Group Study.
        J Clin Oncol. 1991; 9: 572
        • Redner R.L.
        • Corey S.J.
        • Rush E.A.
        Differentiation of t(5;17) variant acute promyelocytic leukemic blasts by all -trans retinoic acid.
        Leukemia. 1997; 11: 1014
        • Redner R.L.
        • Rush E.A.
        • Faas S.
        • et al.
        The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion.
        Blood. 1996; 87: 882
        • Reilly J.T.
        • Barnett D.
        • Dolan G.
        • et al.
        Characterization of an acute micromegakaryocytic leukemia: Evidence for the pathogenesis of myelofibrosis.
        Br J Haematol. 1993; 83: 58
        • Reuss-Borst M.A.
        • Buhring H.J.
        • Schmidt H.
        • et al.
        AML: Immunophenotypic heterogeneity and prognostic significance of c-kit expression.
        Leukemia. 1994; 8: 258
        • Ribeiro R.C.
        • Oliveira M.S.P.
        • Fairclough D.
        • et al.
        Acute megakaryoblastic leukemia in children and adolescents: A retrospective analysis of 24 cases.
        Leukemia Lymphoma. 1993; 10: 299
        • Ribeiro R.C.
        • Pui C.H.
        The clinical and biological correlates of coagulopathy in children with acute leukemia.
        J Clin Oncol. 1986; 4: 1212
        • Robison L.L.
        Down syndrome and leukemia.
        Leukemia. 1992; 6: 5
        • Robison L.L.
        • Buckley J.D.
        • Daigle A.E.
        • et al.
        Maternal drug use and risk of childhood nonlymphoblastic leukemia among offspring. An epidemiologic investigation implicating marijuana (a report from the Childrens Cancer Study Group).
        Cancer. 1989; 63: 1904
        • Rosenthal N.S.
        • Farhi D.C.
        Acute monocytic leukemia with chloroacetate esterase positivity FAB M4 or M5?.
        Am J Clin Pathol. 1992; 98: 41
        • Rothe G.
        • Schmitz G.
        Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies.
        Leukemia. 1996; 10: 877
        • Rovelli A.
        • Biondi A.
        • Rajnoldi A.C.
        • et al.
        Microgranular variant of acute promyelocytic leukemia in children.
        J Clin Oncol. 1992; 10: 1413
        • Rowley J.D.
        Consistent chromosome abnormalities in human leukemia and lymphoma.
        Cancer Invest. 1983; 1: 267
        • Rubnitz J.E.
        • Behm F.G.
        • Downing J.R.
        11q23 rearrangements in acute leukemia.
        Leukemia. 1996; 10: 74
        • San Miguel J.F.
        • Martinez A.
        • Macedo A.
        • et al.
        Immunophenotyping investigation of minimal residual disease is a useful approach for predicting relapse in acute myeloid leukemia patients.
        Blood. 1997; 90: 2465
        • Sariban E.
        • Oliver C.
        • Corash L.
        • et al.
        Acute megakaryoblastic leukemia in childhood.
        Cancer. 1984; 54: 1423
        • Schichman S.A.
        • Caligiuri M.A.
        • Strout M.P.
        • et al.
        ALL-1 tandem duplication in acute myeloid leukemia with a normal karyotype involves homologous recombination between Alu elements.
        Cancer Res. 1994; 54: 4277
        • Schiffer C.A.
        • Wiernik P.H.
        Functional evaluation of circulating leukemic cell in acute non-lymphocytic leukemia.
        Leukemia Res. 1977; 1: 271
        • Segeren C.M.
        • de Jong-Gerritis G.C.M.M.
        • van’t Veer M.B.
        AML-MO: Clinical utility or waste basket for immature blastic leukemias? A description of 14 patients.
        Ann Hematol. 1995; 70: 297
        • Selleri C.
        • Notaro R.
        • Catalando L.
        • et al.
        Prognostic irrelevance of CD34 in acute myeloid leukaemia.
        Br J Haematol. 1992; 82: 479
        • Sempere A.
        • Jarque I.
        • Guinot M.
        • et al.
        Acute myeloblastic leukemia with minimal myeloid differentiation (FAB AML-MO): A study of eleven cases.
        Leuk Lymphoma. 1993; 12: 103
        • Shannon K.M.
        • Watterson J.
        • Johnson P.
        • et al.
        Monosomy 7 myeloproliferative disease in children with neurofibromatosis, Type 1: Epidemiology and molecular analysis.
        Blood. 1992; 79: 1311
        • Shu X.O.
        • Gao Y.T.
        • Brinton L.A.
        • et al.
        A population-based case-control study of childhood leukemia in Shanghai.
        Cancer. 1988; 62: 635
        • Shu X.O.
        • Ross J.A.
        • Pendergrass T.W.
        • et al.
        Parental alcohol consumption, cigarette smoking and risk of infant leukemia: A Children’s Cancer Group Study.
        J Natl Cancer Inst. 1996; 88: 24
        • Shurtleff S.A.
        • Meyers S.
        • Hiebert S.W.
        • et al.
        Heterogeneity in CBFß/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemia.
        Blood. 1995; 85: 3695
        • Slave I.
        • Urban C.
        • Haas O.A.
        • et al.
        Acute megakaryocytic leukemia in children.
        Cancer. 1991; 68: 2266
        • Slovak M.L.
        • Kopecky K.J.
        • Cassileth P.A.
        • et al.
        Karyotypic analysis predicts outcome of pre-and post-remission therapy in adult acute myeloid leukemia (AML): A SWOG/ ECOG intergroup study.
        Blood. 1998; 92: 451
        • Smith F.O.
        • Broudy V.C.
        • Zsebo K.M.
        • et al.
        Cell surface expression of c-kit by childhood acute myeloid leukemia blasts is not of prognostic value: A report for the Childrens Cancer Group.
        Blood. 1994; 84: 847
        • Smith F.O.
        • Lampkin B.C.
        • Versteeg C.
        • et al.
        Expression of lymphoid-associated cell surface antigens by childhood acute myeloid leukemia cell lacks prognostic significance.
        Blood. 1992; 79: 2415
        • Smith M.A.
        • McCaffrey R.P.
        • Karp J.E.
        The secondary leukemias: Challenges and research directions.
        J Natl Cancer Inst. 1996; 88: 407
        • Soekarman D.
        • von Lindern M.
        • van der Plas D.C.
        • et al.
        Dek-Can rearrangement in translocation (6;9)(p23;q34).
        Leukemia. 1992; 6: 489
        • Solary E.
        • Casanovas R.O.
        • Campos L.
        • et al.
        Surface markers in adult acute myeloblastic leukemia: Correlation of CD19 +, CD34+ and CD14+/DR— phenotypes with shorter survival.
        Leukemia. 1992; 6: 393
        • Starnberg J.
        Chromosome abnormalities in erythroleukemia.
        Cancer. 1987; 60: 2649
        • Stasi R.
        • del Poeta G.
        • Venditti A.
        • et al.
        Analysis of treatment failure in patients with minimally differentiated acute myeloid leukemia (AML-MO).
        Blood. 1994; 83: 1619
        • Stass S.
        • Mirro J.
        Unexpected heterogeneity in acute leukemia: Mixed lineages and lineage switch.
        Hum Pathol. 1985; 16: 864
        • Stelzer G.T.
        • Shults K.E.
        • Loken M.R.
        CD45 gating for routine flow cytometric analysis of human bone marrow specimens.
        Ann NY Acad Sei. 1993; 677: 265
        • Stewart C.C.
        • Behm F.G.
        • Carey J.L.
        • et al.
        US-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: Selection of antibody combinations.
        Cytometry. 1997; 30: 231
        • Storr J.
        • Dolan G.
        • Coustan-Smith E.
        • et al.
        Value of monoclonal anti-myeloperoxidase (MP07) for diagnosing acute leukemia.
        J Clin Pathol. 1990; 43: 847
        • Straus D.J.
        • Mertelsmann R.
        • Koziner B.
        • et al.
        The acute monocytic leukemias: Multidisciplinary studies in 45 patients.
        Medicine. 1980; 59: 409
        • Strobl H.
        • Takimoto M.
        • Majdic O.
        • et al.
        Myeloperoxidase expression in CD34 + normal human hematopoietic cells.
        Blood. 1993; 82: 2069
        • Tallman M.S.
        • Andersen J.W.
        • Schiffer C.A.
        • et al.
        All-frans-retinoic acid in acute promyelo-cytic leukemia.
        N Engl J Med. 1997; 337: 1021
        • Tallman M.S.
        • Hakimian D.
        • Snower D.
        • et al.
        Basophilic differentiation in acute promy-elocytic leukemia.
        Leukemia. 1993; 7: 521
        • Tallman M.S.
        • Kwaan H.C.
        Reassessing the hemostatic disorder associated with acute promyelocytic leukemia.
        Blood. 1992; 79: 543
        • Tien H.F.
        • Chou C.C.
        • Wang C.H.
        • et al.
        Putative normal counterparts of leukaemic cells from CD7-positive acute myeloid leukaemia can be demonstrated in human haemopoietic tissues.
        Br J Haematol. 1996; 94: 501
        • Tobal K.
        • Johnson P.R.E.
        • Saunders M.J.
        • et al.
        Detection of CFBß/MYH11 transcripts in patients with inversion and other abnormalities of chromosome 16 at presentation and remission.
        Br J Haematol. 1995; 91: 104
        • Tobal K.
        • Liu Yin J.A.
        RT-PCR method with increased sensitivity shows persistence of PML-RARA fusion transcripts in patients in long-term remission of APL.
        Leukemia. 1998; 12: 1349
        • Tobelem G.
        • Jacquillat C.
        • Chastang C.
        • et al.
        Acute monoblastic leukemia: A clinical and biological study of 74 cases.
        Blood. 1980; 55: 71
        • Tsuchiya H.
        • El Sonbaty S.S.
        • Nagano K.
        • et al.
        Acute myeloblastic leukemia (ANLL-M2) with t(8;21)(q22;q22) variant expressing lymphoid but not myeloid surface antigens with a high number G-CSF receptors.
        Leuk Res. 1993; 17: 375
        • Undritz E.
        Sandoz Atlas of Haematology. ed 2. Frobenius, Basle1973
        • Uckun F.M.
        • Sather H.N.
        • Gaynon P.S.
        • et al.
        Clinical features and treatment outcomes of children with myeloid antigen positive acute lymphoblastic leukemia: A report from the Children’s Cancer Group.
        Blood. 1997; 90: 28
        • Valverde L.R.
        • Matutes E.
        • Farahat N.
        • et al.
        C-kit receptor (CD117) expression in acute leukemia.
        Ann Hematol. 1996; 72: 11
        • Van der Schoot C.E.
        • Daams G.M.
        • Pinkster J.
        • et al.
        Monoclonal antibodies against myeloperoxidase are valuable immunological reagents for the diagnosis of acute myeloid leukaemia.
        Br J Haematol. 1990; 74: 173
        • Van der Schoot C.E.
        • Visser F.J.
        • Tetteroo P.A.T.
        • et al.
        In-vitro differentiation of cells of patients with acute undifferentiated leukaemia.
        Br J Haematol. 1989; 71: 351
        • Velloso E.R.P.
        • Mecucci C.
        • Michaux L.
        • et al.
        Translocation t(8;16)(p11;p13) in acute nonlymphocytic leukemia: Report on two new cases and review of the literature.
        Leuk Lymphoma. 1996; 21: 137
        • Venditti A.
        • del Poeta G.
        • Buccisano F.
        • et al.
        Minimally differentiated acute myeloid leukemia (AML-MO): Comparison of 25 cases with other French-American-British subtypes.
        Blood. 1997; 89: 621
        • Venditti A.
        • del Poeta G.
        • Stasi R.
        • et al.
        Biological profile of 23 cases of minimally differentiated acute myeloid leukemia (AML-MO) and its clinical implications.
        Blood. 1996; 87: 418
        • Vidriales M.B.
        • Orfao A.
        • Gonzalez M.
        • et al.
        Expression of NK and lymphoid-associated antigens in blasts of acute myeloblastic leukemia.
        Leukemia. 1993; 7: 2026
        • Villeval J.L.
        • Cramer P.
        • Lemoine F.
        • et al.
        Phenotype of early erythroblastic leukemias.
        Blood. 1986; 68: 1167
        • von Lindem M.
        • Fornerod M.
        • van Baal S.
        • et al.
        The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA.
        Molecular Cell Biology. 1992; 12: 1687
        • Wang Z.G.
        • Ruggero D.
        • Ronchetti S.
        • et al.
        Pml is essential for multiple apoptotic pathways.
        Nature Genet. 1998; 20: 266
        • Warrell Jr, R.P.
        • de The H.
        • Wang Z.Y.
        • et al.
        Acute promyelocytic leukemia.
        N Engl J Med. 1993; 329: 177
        • Washio S.
        • Ido M.
        • Azuma E.
        • et al.
        Acute megakaryoblastic leukemia with translocation t(1,22)(p13;q13) in a 10-week-old infant.
        Am J Hematol. 1992; 39: 56
        • Weinberg R.A.
        Tumor suppressor genes.
        Science. 1991; 254: 1138
        • Weis K.
        • Ramband S.
        • Lavau C.
        • et al.
        Retinoic acid regulates aberrant nuclear localization of PML/RARa in acute promyelocytic leukemia cells.
        Cell. 1994; 76: 345
        • Weiss K.
        • Stass S.
        • Williams D.
        • et al.
        Childhood monosomy 7 syndrome: Clinical and in vitro studies.
        Leukemia. 1987; 1: 97
        • Wells R.A.
        • Catzavelos C.
        • Kamel-Reid S.
        Fusion of retinoic acid receptor a to NuMA, the nuclear mitotic apparatus protein, by a variant translocation in acute promyelocytic leukemia.
        Nat Genet. 1997; 17: 109
        • Wells R.A.
        • Hummel J.L.
        • De Koven A.
        • et al.
        A new variant translocation in acute promyelocytic leukemia: Molecular characterization and clinical correlation.
        Leukemia. 1996; 10: 735
        • Weltermann A.
        • Pabinger I.
        • Geissler K.
        • et al.
        Hypofibrinogenemia in non-M3 acute myeloid leukemia. Incidence, clinical and laboratory characteristic and prognosis.
        Leukemia. 1998; 12: 1182
        • Westendorf J.J.
        • Yamamoto C.M.
        • Lenny N.
        • et al.
        The t(8;21) fusion product, AML-1-ETO, associates with C/EBP-alpha, inhibits C/EBP-alpha-dependent transcription, and blocks granulocytic differentiation.
        Mol Cell Biol. 1998; 18: 322
        • Wiersma S.R.
        • Ortega J.
        • Sobel E.
        • et al.
        Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood.
        N Engl J Med. 1991; 324: 800
        • Williams C.K.O.
        • Folami A.O.
        • Laditan A.A.O.
        • et al.
        Childhood acute leukaemia in a tropical population.
        Br J Cancer. 1982; 46: 89
        • Windebank K.P.
        • Tefferi A.
        • Smithson W.A.
        • et al.
        Acute megakaryocytic leukemia (M7) in children.
        Mayo Clin Proc. 1989; 64: 1339
        • Yanagisawa K.
        • Fukuoka T.
        • Fujita S.
        Evidence for the neoplastic involvement of monocytic, eosinophilic and basophilic lineages in acute myelomonocytic leukemia with eosinophilia.
        Acta Haematol. 1990; 83: 145
        • Yokose N.
        • Ogata K.
        • Ito T.
        • et al.
        Chemotherapy for minimally differentiated acute myeloid leukemia (AML-MO).
        Ann Hematol. 1993; 66: 67
        • Zaki S.R.
        • Austin G.E.
        • Swan D.C.
        • et al.
        Studies of myeloperoxidase gene expression at the cellular level by in-situ hybridization.
        Leukemia. 1990; 4: 813
        • Zhu J.
        • Koken M.H.M.
        • Quignon F.
        • et al.
        Arsenic-induced PML targeting onto nuclear bodies: Implications for the treatment of acute promyelocytic leukemia.
        Proc Natl Acad Sci U S A. 1997; 94: 3978
        • Zipursky A.
        • Peeters M.
        • Poon A.
        Megakaryoblastic leukemia and Down’s syndrome. A review.
        Pediatr Hematol Oncol. 1987; 4: 211
        • Zipursky A.
        • Poon A.
        • Doyle J.
        Leukemia in Down syndrome: A review.
        Pediatr Hematol Oncol. 1992; 9: 139

      Article info

      Footnotes

      This work was supported in part by grant CA-20180 from the National Cancer Institute, and by the American Lebanese Syrian Associated Charities (ALSCA).

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)30135-5

      Copyright

      © 1999 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX